Ausgabe 12/2022
Inhalt (36 Artikel)
SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management—the EANM perspective
Petra Petranović Ovčariček, Michael C. Kreissl, Alfredo Campenni, Bart de Keizer, Murat Tuncel, Alexis Vrachimis, Desiree Deandreis, Luca Giovanella
[64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation
Fang Xie, Weijun Wei
PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers
Shuxian An, Gang Huang, Jianjun Liu, Weijun Wei
The era of prostate-specific membrane antigen (PSMA)–based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
Luca Filippi, Arthur J. Braat, Orazio Schillaci
Shining new light on lung cancer diagnosis using a pafolacianine molecular tracer
T. Kramer, P. I. Bonta, J. T. Annema
Repair of α-particle-induced DNA damage in peripheral blood mononuclear cells after internal ex vivo irradiation with 223Ra
Lukas Göring, Sarah Schumann, Jessica Müller, Andreas K. Buck, Matthias Port, Michael Lassmann, Harry Scherthan, Uta Eberlein
Predicting response of micrometastases with MIRDcell V3: proof of principle with 225Ac-DOTA encapsulating liposomes that produce different activity distributions in tumor spheroids
Sumudu Katugampola, Jianchao Wang, Aprameya Prasad, Stavroula Sofou, Roger W. Howell
PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [68Ga]Ga-PSMA-617
Qiaomiao Lu, Yu Long, Kevin Fan, Zhiwen Shen, Yongkang Gai, Qingyao Liu, Dawei Jiang, Weibo Cai, Chidan Wan, Xiaoli Lan
The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth
Inna Gertsenshteyn, Boris Epel, Amandeep Ahluwalia, Heejong Kim, Xiaobing Fan, Eugene Barth, Marta Zamora, Erica Markiewicz, Hsiu-Ming Tsai, Subramanian Sundramoorthy, Lara Leoni, John Lukens, Mohammed Bhuiyan, Richard Freifelder, Anna Kucharski, Mihai Giurcanu, Brian B. Roman, Gregory Karczmar, Chien-Min Kao, Howard Halpern, Chin-Tu Chen
Preclinical evaluation and pilot clinical study of [18F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis
Luna Ge, Zheng Fu, Yuchun Wei, Dandan Shi, Yun Geng, Huancai Fan, Ruojia Zhang, Yuang Zhang, Shufeng Li, Shijie Wang, Haojun Shi, Guanhua Song, Jihong Pan, Kai Cheng, Lin Wang
A first-in-human study of [68Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death
Ivan Ho Shon, Thomas Hennessy, Jennifer Guille, Michael P. Gotsbacher, Angelina J. Lay, Bruce McBride, Rachel Codd, Philip J. Hogg
Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks
Neda Zaker, Kamal Haddad, Reza Faghihi, Hossein Arabi, Habib Zaidi
Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy
Song Xue, Andrei Gafita, Chao Dong, Yu Zhao, Giles Tetteh, Bjoern H. Menze, Sibylle Ziegler, Wolfgang Weber, Ali Afshar-Oromieh, Axel Rominger, Matthias Eiber, Kuangyu Shi
In vivo detection of hydrogen sulfide in the brain of live mouse: application in neuroinflammation models
Bora Nam, Woonghee Lee, Swarbhanu Sarkar, Jae-Hong Kim, Abhinav Bhise, Hyun Park, Jung Young Kim, Phuong Tu Huynh, Subramani Rajkumar, Kiwoong Lee, Yeong Su Ha, Seong Hwan Cho, Jeong Eun Lim, Kyung Won Kim, Kyo Chul Lee, Kyoungho Suk, Jeongsoo Yoo
PET/CT imaging of CSF1R in a mouse model of tuberculosis
Catherine A. Foss, Alvaro A. Ordonez, Ravi Naik, Deepankar Das, Andrew Hall, Yunkou Wu, Robert F. Dannals, Sanjay K. Jain, Martin G. Pomper, Andrew G. Horti
A comparison of advanced semi-quantitative amyloid PET analysis methods
Enrico Peira, Davide Poggiali, Matteo Pardini, Henryk Barthel, Osama Sabri, Silvia Morbelli, Annachiara Cagnin, Andrea Chincarini, Diego Cecchin
Improving the imaging diagnostic strategy for pulmonary artery masses based on 18F-FDG PET/CT integrated with CTPA
Cheng Hong, Peng Hou, Hai-ming Chen, Kai-xiang Zhong, Wen-liang Guo, Jie-long Lin, Xiao-feng Wu, Yong-xia Lei, Qiong Jia, Chun-li Liu, Shi-yue Li, Xin-lu Wang
Reproducibility of quantitative coronary calcium scoring from PET/CT attenuation maps: comparison to ECG-gated CT scans
Konrad Pieszko, Aakash D. Shanbhag, Mark Lemley, Mark Hyun, Serge Van Kriekinge, Yuka Otaki, Joanna X. Liang, Daniel S. Berman, Damini Dey, Piotr J. Slomka
CXCR4-targeted theranostics in oncology
Andreas K. Buck, Sebastian E. Serfling, Thomas Lindner, Heribert Hänscheid, Andreas Schirbel, Stefanie Hahner, Martin Fassnacht, Hermann Einsele, Rudolf A. Werner
Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG
Wanqi Chen, Lei Liu, Yinghe Li, Shatong Li, Zhijian Li, Weiguang Zhang, Xu Zhang, Runze Wu, Debin Hu, Hongyan Sun, Yun Zhou, Wei Fan, Yumo Zhao, Yizhuo Zhang, Yingying Hu
Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography
Yu Long, Xiaoying Lv, Xiangming Song, Fuqiang Shao, Hao Ji, Yirui Zhang, Pengxin Qiao, Qingyao Liu, Xiaotian Xia, Ping Lei, Yongkang Gai, Xiaoli Lan
Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study
Yan-Song Lin, Hui Yang, Xiao-Yi Li, Li-Qing Wu, Jin-Guo Xu, Ai-Min Yang, Zai-Rong Gao, Yong Ding, Ying-Qiang Zhang, Kai Chen, Zhuan-Zhuan Mu, Jian-Min Jia, Na Niu, Di Sun, Xin Zhang, Shao-Qiang Zhang, Qian-Qian Geng, Ya-Jing Zhang, Fang-Ni Chen, Bao-Xia He
Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
Vittoria Rufini, Margherita Lorusso, Frediano Inzani, Tina Pasciuto, Elizabeth Katherine Anna Triumbari, Lucia Rosalba Grillo, Filippo Locco, Stefano Margaritora, Edoardo Pescarmona, Guido Rindi
Targeted detection of cancer cells during biopsy allows real-time diagnosis of pulmonary nodules
Gregory T. Kennedy, Feredun S. Azari, Elizabeth Bernstein, Bilal Nadeem, Ashley Chang, Alix Segil, Neil Sullivan, Emmanuel Encarnado, Charuhas Desphande, John C. Kucharczuk, Kaela Leonard, Philip S. Low, Silvia Chen, Aline Criton, Sunil Singhal
Diagnostic performance of [18F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis
Seyed Ali Mirshahvalad, Ricarda Hinzpeter, Andres Kohan, Reut Anconina, Roshini Kulanthaivelu, Claudia Ortega, Ur Metser, Patrick Veit-Haibach
A prospective head-to-head comparison of 68 Ga-NOTA-3P-TATE-RGD and 68 Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours
Yuanyuan Jiang, Qingxing Liu, Guochang Wang, Huimin Sui, Rongxi Wang, Jiarou Wang, Zhaohui Zhu
Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management
Chunxia Qin, Yangmeihui Song, Yongkang Gai, Weiwei Ruan, Qingyao Liu, Fang Liu, Danzha Zheng, Peng Zhang, Hongli Liu, Tao Zhang, Kaixiong Tao, Xiaoli Lan
The role of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma
Xiaoyan Wang, Weixiong Yang, Qian Zhou, Hui Luo, Wenfang Chen, Sai-Ching Jim Yeung, Shuishen Zhang, Yi Gan, Bo Zeng, Zhenguo Liu, Shiting Feng, Xiangsong Zhang, Chao Cheng
Comparing the clinical performance and cost efficacy of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis
Ian Alberts, Clemens Mingels, Helle D. Zacho, Sabine Lanz, Heiko Schöder, Axel Rominger, Marcel Zwahlen, Ali Afshar-Oromieh
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up
Philipp E. Hartrampf, Anna Katharina Seitz, Franz-Xaver Weinzierl, Sebastian E. Serfling, Andreas Schirbel, Steven P. Rowe, Hubert Kübler, Andreas K. Buck, Rudolf A. Werner
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
Andrei Gafita, Isabel Rauscher, Wolfgang P. Fendler, Vishnu Murthy, Wang Hui, Wesley R. Armstrong, Ken Herrmann, Wolfgang A. Weber, Jeremie Calais, Matthias Eiber, Manuel Weber, Matthias R. Benz
Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
Stefanie Quach, Adrien Holzgreve, Louisa von Baumgarten, Maximilian Niyazi, Marcus Unterrainer, Niklas Thon, Sophia Stöcklein, Peter Bartenstein, Jörg-Christian Tonn, Nathalie L. Albert
Primary biphasic synovial sarcoma of the liver with multiple bone metastases detected by PET/CT
Miao Liu, Hua Shang, Lingge Wei, Jianmin Huang, Peng Xie
Complementary value of metabolic and tau PET imaging in the diagnosis of corticobasal degeneration
Menglin Liang, Chenhao Jia, Tzu-Chen Yen, Linwen Liu, Mingli Li, Ruixue Cui
Correction to: Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
Vittoria Rufini, Margherita Lorusso, Frediano Inzani, Tina Pasciuto, Elizabeth Katherine Anna Triumbari, Lucia Rosalba Grillo, Filippo Lococo, Stefano Margaritora, Edoardo Pescarmona, Guido Rindi
Correction to: Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography
Yu Long, Xiaoying Lv, Xiangming Song, Fuqiang Shao, Hao Ji, Yirui Zhang, Pengxin Qiao, Qingyao Liu, Xiaotian Xia, Ping Lei, Yongkang Gai, Xiaoli Lan